# Precision Optical Guidance for Oral Biopsy

> **NCT05554133** · NA · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 90 (estimated)

## Conditions studied

- Oral Lesions

## Interventions

- **DEVICE:** High Resolution Microendoscope (HRME)
- **DEVICE:** Optical Mapping Scope
- **DRUG:** Proflavine hemisulfate

## Key facts

- **NCT ID:** NCT05554133
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-15
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05554133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05554133, "Precision Optical Guidance for Oral Biopsy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05554133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*